Condition

Mesenchymal Stem Cells

ClinicalTrials.gov condition label

Clinical trials8

Recruiting0

Common interventions8

Lead sponsors shown7

Clinical trials

8 shown

Open Label Single Arm Proof of Concept Trial to Evaluate the Efficacy and Safety of Cytori Celution System in Diabetic Leg UlcersNCT05274295 · 2022-02-28

Efficacy and Safety of Umbilical Cord Mesenchymal Stem Cells Transplantation in Patients With Type 2 Diabetes MellitusNCT04441658 · 2020-04-10

Umbilical Cord Mesenchymal Stem Cells Therapy for Diabetic NephropathyNCT04125329 · 2020-04-01

Evaluate the Safety and Feasibility of Allogeneic Mesenchymal Stem Cells in Patients With Multiple SclerosisNCT06360861 · 2019-07-23

Mesenchymal Stem Cells to Treat Type 2 DiabetesNCT02302599 · 2013-01-01

Umbilical Cord Mesenchymal Stem Cells Injection for Diabetic FootNCT01216865 · 2011-01-01

Umbilical Cord Mesenchymal Stem Cells Infusion for Initial Type 1 Diabetes MellitusNCT01219465 · 2010-09-01

Allogeneic Mesenchymal Stem Cells Transplantation for Primary Sjögren's Syndrome (pSS)NCT00953485 · 2009-06-01

Common interventions

Umbilical Cord Mesenchymal Stem CellsBIOLOGICAL4 Allogeneic Mesenchymal Stem Cells (AlloMSC)BIOLOGICAL1 Allogenic placenta derived mesenchymal stem cellsBIOLOGICAL1 Controlled suspension liquidBIOLOGICAL1 Diabetic leg ulcer treatment with adipous SVFDEVICE1 Human umbilical cord mesenchymal stem cellsDRUG1 salineBIOLOGICAL1 Standard TherapyDRUG1

Leading sponsors

Qingdao University2 Chinese PLA General Hospital1 Shanghai East Hospital1 Szeged University1 Tehran University of Medical Sciences1 The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School1 Yan'an Affiliated Hospital of Kunming Medical University1

Trial status mix

UNKNOWN6

COMPLETED2

Phase mix

PHASE15

PHASE25

EARLY_PHASE11

NA1

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.